OBJECTIVE: To determine whether socioemotional disinhibition and executive dysfunction are related to dissociable patterns of brain atrophy in neurodegenerative disease. Previous studies have indicated that behavioral and cognitive dysfunction in neurodegenerative disease are linked to atrophy in different parts of the frontal lobes, but these prior studies did not establish that these relationships were specific, which would best be demonstrated by a double dissociation. METHOD: Subjects included 157 patients with neurodegenerative disease. A semiautomated parcellation program (Freesurfer) was used to generate regional cortical volumes from structural MRI scans. Regions of interest (ROIs) included anterior cingulate cortex (ACC), orbitofrontal cortex (OFC), middle frontal gyrus (MFG), and inferior frontal gyrus (IFG). Socioemotional disinhibition was measured using the Neuropsychiatric Inventory. Principal component analysis including 3 tasks of executive function (EF; verbal fluency, Stroop Interference, modified Trails) was used to generate a single-factor score to represent EF. RESULTS: Partial correlations between ROIs, disinhibition, and EF were computed after controlling for total intracranial volume, Mini-Mental State Examination, diagnosis, age, and education. Brain regions significantly correlated with disinhibition (ACC, OFC, IFG, and temporal lobes) and EF (MFG) were entered into separate hierarchical regressions to determine which brain regions predicted disinhibition and EF. OFC was the only brain region to significantly predict disinhibition, and MFG significantly predicted EF performance. A multivariate general linear model demonstrated a significant interaction between ROIs and cognitive-behavioral functions. CONCLUSIONS: These results support a specific association between orbitofrontal areas and behavioral management as compared with dorsolateral areas and EF. (c) 2011 APA, all rights reserved
OBJECTIVE: To determine whether socioemotional disinhibition and executive dysfunction are related to dissociable patterns of brain atrophy in neurodegenerative disease. Previous studies have indicated that behavioral and cognitive dysfunction in neurodegenerative disease are linked to atrophy in different parts of the frontal lobes, but these prior studies did not establish that these relationships were specific, which would best be demonstrated by a double dissociation. METHOD: Subjects included 157 patients with neurodegenerative disease. A semiautomated parcellation program (Freesurfer) was used to generate regional cortical volumes from structural MRI scans. Regions of interest (ROIs) included anterior cingulate cortex (ACC), orbitofrontal cortex (OFC), middle frontal gyrus (MFG), and inferior frontal gyrus (IFG). Socioemotional disinhibition was measured using the Neuropsychiatric Inventory. Principal component analysis including 3 tasks of executive function (EF; verbal fluency, Stroop Interference, modified Trails) was used to generate a single-factor score to represent EF. RESULTS: Partial correlations between ROIs, disinhibition, and EF were computed after controlling for total intracranial volume, Mini-Mental State Examination, diagnosis, age, and education. Brain regions significantly correlated with disinhibition (ACC, OFC, IFG, and temporal lobes) and EF (MFG) were entered into separate hierarchical regressions to determine which brain regions predicted disinhibition and EF. OFC was the only brain region to significantly predict disinhibition, and MFG significantly predicted EF performance. A multivariate general linear model demonstrated a significant interaction between ROIs and cognitive-behavioral functions. CONCLUSIONS: These results support a specific association between orbitofrontal areas and behavioral management as compared with dorsolateral areas and EF. (c) 2011 APA, all rights reserved
Authors: H J Rosen; M L Gorno-Tempini; W P Goldman; R J Perry; N Schuff; M Weiner; R Feiwell; J H Kramer; B L Miller Journal: Neurology Date: 2002-01-22 Impact factor: 9.910
Authors: Dana Wittenberg; Katherine L Possin; Katya Rascovsky; Katherine P Rankin; Bruce L Miller; Joel H Kramer Journal: Neuropsychol Rev Date: 2008-02-29 Impact factor: 7.444
Authors: M Løvstad; I Funderud; T Endestad; P Due-Tønnessen; T R Meling; M Lindgren; R T Knight; A K Solbakk Journal: Brain Inj Date: 2012-06-25 Impact factor: 2.311
Authors: Lara H Heflin; Victor Laluz; Jung Jang; Robin Ketelle; Bruce L Miller; Joel H Kramer Journal: Neuropsychology Date: 2011-09 Impact factor: 3.295
Authors: N Gregg; A Arber; K Ashkan; L Brazil; R Bhangoo; R Beaney; R Gullan; V Hurwitz; A Costello; L Yágüez Journal: Support Care Cancer Date: 2014-05-28 Impact factor: 3.603
Authors: Arne Møller; Valerie Voon; Casper Schmidt; Nikolina Skandali; Carsten Gleesborg; Timo L Kvamme; Hema Schmidt; Kim Frisch Journal: Neuropsychopharmacology Date: 2020-05-11 Impact factor: 7.853